Cancer diagnosis can be challenging, and delayed diagnosis can allow cancer to progress, complicating treatment. Oral ...
Osaka, Japan – Cancer diagnosis can be challenging, and delayed diagnosis can allow cancer to progress, complicating treatment. Oral squamous cell carcinoma (OSCC), the most common type of oral cancer ...
Oral squamous cell carcinoma (OSCC) progresses from seemingly benign preneoplastic lesions, but understanding the epigenetic triggers for this transition remains limited. A new study reveals ...
The Israeli Ministry of Health (IL MOH) has approved BeiGene’s TEVIMBRA (tislelizumab) as a monotherapy to treat adults with unresectable or metastatic oesophageal squamous cell carcinoma (OSCC) who ...
Oral squamous cell cancer, or OSCC, arises in the cells that line the mouth. The disease is often diagnosed at a late stage, which comes with a poor prognosis, and 450,000 people die from it every ...
A collaborative research team from The University of Hong Kong (HKU) and West China Hospital of Sichuan University has made a breakthrough in understanding the spread of oral squamous cell carcinoma ...
Trends in neuroendocrine tumor-related mortality, 1999–2020: A CDC WONDER database analysis. Postoperative radioiodine (RAI) versus no radiodine therapy for patients with low-risk differentiated ...
Head and neck cancer (HNC) is a devastating disease associated with tobacco smoking. Tobacco smoke-related mRNA phenotypes in HNC were previously documented in vivo and may be differentially expressed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results